Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Neuhaus

Showing results (551-560 of 830) with videos related to

Pageof 83
Sort By:
Acta Radiologica (Stockholm, Sweden : 1987)|October 4, 2000
Transjugular intrahepatic portosystemic shunt. Experiences at a liver transplantation centerN Hidajat, T Vogl, H Stobbe, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1994
Optimal FK 506 dosage in patients under primary immunosuppression following liver transplantationM Winkler, R Pichlmayr, P Neuhaus, et al.
Transplantation Proceedings|May 17, 2000
Infectious complications after orthotopic liver transplantation with different immunosuppressive induction regimensR Lohmann, J M Langrehr, J Klupp, et al.
Transplantation Proceedings|June 1, 1991
Strategy for prevention of infection after orthotopic liver transplantationR Rossaint, R Raakow, K Lewandowski, et al.
Surgery|April 1, 1997
Female sex hormone receptor status in advanced hepatocellular carcinoma and outcome after surgical resectionS Jonas, W O Bechstein, T Heinze, et al.
Deutsche Medizinische Wochenschrift (1946)|June 1, 1984
[Differential nuclear medicine diagnosis of intrahepatic space-occupying diseases]H Creutzig, C Brölsch, K Gratz, et al.
Transplantation Proceedings|June 24, 1998
Donor-recipient sex matching and posttransplant malignancies after induction therapy in hepatic transplantationS Jonas, U Neumann, O Guckelberger, et al.
Transplantation|August 13, 1998
Pretransplant virological markers hepatitis C virus genotype and viremia level are not helpful in predicting individual outcome after orthotopic liver transplantationT Berg, U Hopf, W O Bechstein, et al.
Transplantation Proceedings|September 24, 1998
Extracellular matrix: an early target of preservation/reperfusion injury and acute rejection after small bowel transplantationA R Mueller, K P Platz, C Heckert, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 26, 2000
Lamivudine as first- and second-line treatment of hepatitis B infection after liver transplantationD Seehofer, N Rayes, T Berg, et al.
Pageof 83

Showing results (551-560 of 830) with videos related to

Sort By:
Pageof 83
Acta Radiologica (Stockholm, Sweden : 1987)|October 4, 2000
Transjugular intrahepatic portosystemic shunt. Experiences at a liver transplantation centerN Hidajat, T Vogl, H Stobbe, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1994
Optimal FK 506 dosage in patients under primary immunosuppression following liver transplantationM Winkler, R Pichlmayr, P Neuhaus, et al.
Transplantation Proceedings|May 17, 2000
Infectious complications after orthotopic liver transplantation with different immunosuppressive induction regimensR Lohmann, J M Langrehr, J Klupp, et al.
Transplantation Proceedings|June 1, 1991
Strategy for prevention of infection after orthotopic liver transplantationR Rossaint, R Raakow, K Lewandowski, et al.
Surgery|April 1, 1997
Female sex hormone receptor status in advanced hepatocellular carcinoma and outcome after surgical resectionS Jonas, W O Bechstein, T Heinze, et al.
Deutsche Medizinische Wochenschrift (1946)|June 1, 1984
[Differential nuclear medicine diagnosis of intrahepatic space-occupying diseases]H Creutzig, C Brölsch, K Gratz, et al.
Transplantation Proceedings|June 24, 1998
Donor-recipient sex matching and posttransplant malignancies after induction therapy in hepatic transplantationS Jonas, U Neumann, O Guckelberger, et al.
Transplantation|August 13, 1998
Pretransplant virological markers hepatitis C virus genotype and viremia level are not helpful in predicting individual outcome after orthotopic liver transplantationT Berg, U Hopf, W O Bechstein, et al.
Transplantation Proceedings|September 24, 1998
Extracellular matrix: an early target of preservation/reperfusion injury and acute rejection after small bowel transplantationA R Mueller, K P Platz, C Heckert, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 26, 2000
Lamivudine as first- and second-line treatment of hepatitis B infection after liver transplantationD Seehofer, N Rayes, T Berg, et al.
Pageof 83